Antiretroviral Therapy Initiation and Changes in Self-Reported Depression | Zendy

Ellen Eaton | Zendy; Ronnie M. Gravett | Zendy; Ashutosh Tamhane | Zendy; Michael J. Mugavero | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antiretroviral Therapy Initiation and Changes in Self-Reported Depression

Author(s) -

Ellen Eaton,

Ronnie M. Gravett,

Ashutosh Tamhane,

Michael J. Mugavero

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix217

Subject(s) - medicine , interquartile range , efavirenz , depression (economics) , antiretroviral therapy , retrospective cohort study , patient health questionnaire , human immunodeficiency virus (hiv) , physical therapy , psychiatry , viral load , depressive symptoms , family medicine , macroeconomics , anxiety , economics

In this retrospective study of treatment-naive PLWH initiating antiretroviral therapy, the score for the depression scale of the Patient Health Questionnaire (PHQ-9) was significantly higher at baseline (median, 6.0; interquartile range, 2-11) than at 12 months (3.0; 0-8; P < .001). Baseline depression and lack of insurance are associated with 12-month depression, but receipt of efavirenz-based antiretroviral therapy is not.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research